U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355634) titled 'Terraflora Daily Care and Gastrointestinal Health' on Jan. 02.

Brief Summary: A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Gastrointestinal

Intervention: DIETARY_SUPPLEMENT: Synbiotic Dietary Supplement

12 weeks of supplementation with Enviromedica - Terraflora Daily Care

DIETARY_SUPPLEMENT: Placebo

Placebo capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: OvationLab

Disclaimer: Curate...